AbbVie's $46.5 Billion Bid for Shire Rejected

AbbVie's $46.5 Billion Bid for Shire Rejected Play

June 20 (Bloomberg) -- AbbVie Inc., the U.S. drugmaker split last year from Abbott Laboratories, said three escalating offers to buy Shire Plc for as much as 27.3 billion pounds ($46.5 billion) were rejected by the Dublin-based company. Matt Campbell reports on Bloomberg Television's "On the Move" with Anna Edwards. (Source: Bloomberg)

  • On Air Now

    Bloomberg Bottom Line Watch Now

  • Next

    Street Smart with Trish Regan

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus